Clinical trial
Evaluating Use of Continuous Glucose Monitors in a Short-term 2x2-Crossover Study
NCT04424888 is registered in ClinicalTrials.gov with Pendulum Therapeutics as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluating Use of Continuous Glucose Monitors in a Short-term 2x2-Crossover Study
- Lead sponsor
- Pendulum Therapeutics
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- March 15, 2018
- Completion date
- June 29, 2018
- Enrollment
- 6 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
diabetes mellitus, diabetes type 2